Tips for searching:
• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Taltz ® (ixekizumab)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).
How should patients store Taltz® (ixekizumab) during transport and travel?
Store ixekizumab at 2 ºC – 8 ºC and in the original carton to protect it from light. Patients may store ixekizumab at room temperature not above 30 ºC for up to 5 days. During travel, store in carry-on luggage.
Transporting the device from the pharmacy
Patients have 5 days available to store ixekizumab unrefrigerated at a temperature not above 30 °C.1 These 5 days may be broken up into multiple exposures (see section Patients only:) and may be used to take ixekizumab home from the pharmacy.
When for example, transport takes 1 hour, patients will still have another 4 days and 23 hours available to store ixekizumab at a temperature not above 30 °C.
Storage conditions for patients travelling with ixekizumab
- Store ixekizumab in a refrigerator (2 ºC – 8 ºC).
- Do not freeze.
- Store in the original package to protect it from light.1
Ixekizumab may be stored unrefrigerated for up to 5 days at a temperature not above 30º C.1
The allowable room temperature storage time may be one single 5-day exposure or can be broken up into multiple exposures. There is no limit to the number of room temperature exposures as long as the total time does not exceed 5 days (120 hours) for each individual device.2
Travel cooler bags
Eli Lilly and Company does not provide cooler bags to travel with Ixekizumab. Patients can refer to their pharmacist about finding a suitable product. Lilly does not test, market or sell these products; therefore, we cannot recommend any of them.2
When using a cooler bag, the device should not be in direct contact with ice, frozen gel packs or freezing temperatures (0°C or below). In addition, protect the medicine from light and freezing temperatures.2
Air travel and security check
When travelling on a plane:
- Ixekizumab should be kept in carry-on luggage. Do not pack in checked luggage. Luggage hold areas may be too cold or too hot.
- Changes in altitude that may be experienced when travelling do not impact the dose accuracy of Ixekizumab.
- The screening equipment used at airports (X-rays) is not known to affect Ixekizumab.2
At customs, patients should be prepared to explain why they are carrying their medicines.
Patients travelling internationally need to check with the authorities in the country of destination about any rules and restrictions they may have for people travelling with medicines, especially if the destination is outside European Union.
1Taltz [summary of product characteristics]. Eli Lilly and Company (Ireland) Limited, Ireland
2Data on file, Eli Lilly and Company and/or one of its subsidiaries.
Date of Last Review: 09 May 2023